Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T18:42:42.132Z.
Calculation as of: 2026-10-06T18:42:42.132Z.
Quote observation: 2026-10-06T18:40:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: be51af8dbdcf828107064bcf61af75d59853c311cbc38d104ed49a07c9c6f929
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
ORIC Pharmaceuticals, Inc.
Market Cap
$1.20B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.20B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.21B
Operating Cash Flow Yield
N/A
TTM Avg
2.26%
3Y Avg
2.23%
5Y Avg
2.23%
Market Cap
$1.22B
Operating Cash Flow Yield
5.31%
TTM Avg
4.74%
3Y Avg
4.15%
5Y Avg
3.70%
Market Cap
$1.17B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.22B
Operating Cash Flow Yield
1.94%
TTM Avg
2.00%
3Y Avg
2.00%
5Y Avg
2.00%
Market Cap
$1.22B
Operating Cash Flow Yield
4.91%
TTM Avg
3.02%
3Y Avg
2.54%
5Y Avg
2.54%
Market Cap
$1.14B
Operating Cash Flow Yield
N/A
TTM Avg
11.23%
3Y Avg
11.23%
5Y Avg
11.23%
Market Cap
$1.14B
Operating Cash Flow Yield
16.20%
TTM Avg
15.61%
3Y Avg
12.04%
5Y Avg
9.55%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ORIC Pharmaceuticals, Inc. (ORIC) | $1.20B | N/A | N/A | N/A | N/A |
| Tyra Biosciences, Inc. (TYRA)vs › | $1.20B | N/A | N/A | N/A | N/A |
| MannKind Corporation (MNKD)vs › | $1.21B | N/A | 2.26% | 2.23% | 2.23% |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 5.31% | 4.74% | 4.15% | 3.70% |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.17B | N/A | N/A | N/A | N/A |
| Omada Health (OMDA)vs › | $1.22B | 1.94% | 2.00% | 2.00% | 2.00% |
| Cronos Group Inc. (CRON)vs › | $1.22B | 4.91% | 3.02% | 2.54% | 2.54% |
| Nektar Therapeutics (NKTR)vs › | $1.14B | N/A | 11.23% | 11.23% | 11.23% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 16.20% | 15.61% | 12.04% | 9.55% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.14B | 17.65% | 18.66% | 11.11% | 8.71% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
